HomeNDRA • NASDAQ
add
ENDRA Life Sciences Inc
Previous close
$3.95
Day range
$3.41 - $3.95
Year range
$3.15 - $693.00
Market cap
2.05M USD
Avg Volume
56.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.30M | 194.75% |
Net income | -4.15M | -184.27% |
Net profit margin | — | — |
Earnings per share | 25.20 | 108.47% |
EBITDA | -4.29M | -198.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.23M | 13.96% |
Total assets | 4.45M | -34.08% |
Total liabilities | 1.89M | 72.76% |
Total equity | 2.56M | — |
Shares outstanding | 562.21K | — |
Price to book | 0.83 | — |
Return on assets | -167.43% | — |
Return on capital | -207.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.15M | -184.27% |
Cash from operations | -1.52M | 30.30% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.52M | -202.76% |
Free cash flow | -2.60M | -347.13% |
About
Founded
2008
Headquarters
Website
Employees
21
